Company intelligence / Profile preview

T-Neuro Pharma

Albuquerque, New Mexico, United Statestneuropharma.com ↗

Ownership: Private
Development stage: Preclinical

Overview

The company has published groundbreaking research in PNAS identifying a critical event in Alzheimer's progression that occurs before the formation of plaques and tangles. Their research shows that specific T cells enter the brain and target neurons, initiating events that lead to Alzheimer's pathologies. These T cells can be detected in blood, enabling early disease identification.

Therapeutic areas: Neurology
Industry: Protein Biomarker Diagnostics

Partnerships

University of AntwerpUniversity of Groningen

Beyond the preview

Go deeper on T-Neuro Pharma.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on T-Neuro Pharma.

Explore the full profile